v3.24.3
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Related Party
Nonrelated Party
Preferred Stock
Common Stock
Common Stock
Related Party
Common Stock
Nonrelated Party
Additional Paid-in Capital
Additional Paid-in Capital
Related Party
Additional Paid-in Capital
Nonrelated Party
Accumulated Deficit
Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjustment
Beginning balance (in shares) at Dec. 31, 2022         9,566                
Beginning balance at Dec. 31, 2022 $ 117,754       $ 9,273 $ 145     $ 294,810     $ (186,474)  
Beginning balance (in shares) at Dec. 31, 2022           145,492,971              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Common stock reacquired in exchange for warrants (in shares)           (12,000,000)              
Common stock reacquired in exchange for warrants (12,491)         $ (12)     (12,479)        
Warrant issuance in conjunction with debt modification 16,036               16,036        
Warrant offerings 14,991               14,991        
Warrant exercise (in shares)           27,258,005              
Warrant exercise 3,527         $ 27     3,500        
Common stock offering, net of issuance costs (in shares)           54,663,601              
Common stock offering, net of issuance costs 54,134         $ 55     54,079        
Convertible promissory notes converted to common stock (in shares)           11,762,956              
Convertible promissory notes converted to common stock 4,705         $ 12     4,693        
Issuance of stock for stock-based compensation/liabilities (in shares)             2,460,513 3,084,780          
Issuance of stock for stock-based compensation/liabilities     $ 15,000 $ 4,026     $ 2 $ 3   $ 14,998 $ 4,023    
Tax withholdings related to net share settlements of stock-based compensation awards (in shares)           (500,494)              
Tax withholdings related to net share settlements of stock-based compensation awards (852)               (852)        
Net loss (62,896)                     (62,896)  
Ending balance (in shares) at Sep. 30, 2023         9,566                
Ending balance at Sep. 30, 2023 153,934       $ 9,273 $ 232     393,799     (249,370)  
Ending balance (in shares) at Sep. 30, 2023           232,222,332              
Beginning balance (in shares) at Dec. 31, 2022         9,566                
Beginning balance at Dec. 31, 2022 $ 117,754       $ 9,273 $ 145     294,810     (186,474)  
Beginning balance (in shares) at Dec. 31, 2022           145,492,971              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Accounting Standards Update [Extensible Enumeration] Accounting Standards Update 2023-08 [Member]                        
Ending balance (in shares) at Dec. 31, 2023 9,566       9,566                
Ending balance at Dec. 31, 2023 $ 222,489 $ 37     $ 9,273 $ 277     472,834     (259,895) $ 37
Ending balance (in shares) at Dec. 31, 2023 276,733,329         276,733,329              
Beginning balance (in shares) at Jun. 30, 2023         9,566                
Beginning balance at Jun. 30, 2023 $ 134,818       $ 9,273 $ 216     355,600     (230,271)  
Beginning balance (in shares) at Jun. 30, 2023           216,055,887              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Warrant exercise (in shares)           1,610,184              
Warrant exercise 14         $ 1     13        
Common stock offering, net of issuance costs (in shares)           10,850,699              
Common stock offering, net of issuance costs 21,786         $ 11     21,775        
Issuance of stock for stock-based compensation/liabilities (in shares)             2,460,513 1,245,049          
Issuance of stock for stock-based compensation/liabilities     $ 15,000 1,415     $ 2 $ 2   14,998 1,413    
Net loss (19,099)                     (19,099)  
Ending balance (in shares) at Sep. 30, 2023         9,566                
Ending balance at Sep. 30, 2023 $ 153,934       $ 9,273 $ 232     393,799     (249,370)  
Ending balance (in shares) at Sep. 30, 2023           232,222,332              
Beginning balance (in shares) at Dec. 31, 2023 9,566       9,566                
Beginning balance at Dec. 31, 2023 $ 222,489 $ 37     $ 9,273 $ 277     472,834     (259,895) $ 37
Beginning balance (in shares) at Dec. 31, 2023 276,733,329         276,733,329              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Warrant exercise (in shares)           31,534,861              
Warrant exercise $ 4,193         $ 31     4,162        
Common stock offering, net of issuance costs (in shares)     1,083,189     67,368,125              
Common stock offering, net of issuance costs 189,214   $ 2,500     $ 68     189,146        
Issuance of stock for stock-based compensation/liabilities (in shares)             1,083,189 9,912,624          
Issuance of stock for stock-based compensation/liabilities     $ 2,500 $ 14,181     $ 1 $ 6   $ 2,499 $ 14,175    
Tax withholdings related to net share settlements of stock-based compensation awards (in shares)           (4,000,045)              
Tax withholdings related to net share settlements of stock-based compensation awards (16,761)               (16,761)        
Net loss $ (43,222)                     (43,222)  
Ending balance (in shares) at Sep. 30, 2024 9,566       9,566                
Ending balance at Sep. 30, 2024 $ 372,631       $ 9,273 $ 383     666,055     (303,080)  
Ending balance (in shares) at Sep. 30, 2024 382,632,083         382,632,083              
Beginning balance (in shares) at Jun. 30, 2024         9,566                
Beginning balance at Jun. 30, 2024 $ 386,241       $ 9,273 $ 374     656,941     (280,347)  
Beginning balance (in shares) at Jun. 30, 2024           374,456,722              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Warrant exercise (in shares)           2,292,200              
Warrant exercise 2,292         $ 2     2,290        
Common stock offering, net of issuance costs (in shares)           3,546,036              
Common stock offering, net of issuance costs 15,520         $ 4     15,516        
Issuance of stock for stock-based compensation/liabilities (in shares)           4,772,478              
Issuance of stock for stock-based compensation/liabilities 2,408         $ 3     2,405        
Tax withholdings related to net share settlements of stock-based compensation awards (in shares)           (2,435,353)              
Tax withholdings related to net share settlements of stock-based compensation awards (11,097)               (11,097)        
Net loss $ (22,733)                     (22,733)  
Ending balance (in shares) at Sep. 30, 2024 9,566       9,566                
Ending balance at Sep. 30, 2024 $ 372,631       $ 9,273 $ 383     $ 666,055     $ (303,080)  
Ending balance (in shares) at Sep. 30, 2024 382,632,083         382,632,083